Written: March 10, 2017Edited and Republished: October 23, 2021 The following article was published in LinkedIn four and a half years ago. Except for price transparency, which has not yet been fully complied with, not much has happened. Americans are …

Healthcare Common Sense: What Should Congress and the President Do? Read more »

In March 2015, Health Attitude: Unraveling and Solving the Complexities of Healthcare was published. One of the recommendations made in the book, to address the spiraling healthcare cost for Americans, was to allow Medicare to negotiate the price of drugs. It was …

Medicare to Negotiate with Pharmaceutical Industry Read more »

Last week, the new Health and Human Services (HHS) Secretary, Alex Azar, said, “Change is possible, change is necessary, and change is coming.” I hope so. Change is desperately needed. It remains to be seen if the federal government can …

Big Changes Coming to Healthcare Read more »

At a rally in Kentucky, President Donald Trump said drug prices were “outrageous”. The next day, according to Kaiser Health News, the pharmaceutical industry donated more money to political campaigns than any other day this year. On March 21, eight pharma …

Big Pharma and Politics Read more »